Non-covalent inhibitors of rhinovirus 3C protease

Non-covalent inhibitors of rhinovirus 3C protease Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors Substituted Benzamide Inhibitors of Human Rhinovirus 3C Protease:  Structure-Based Design, Synthesis, and Biological Evaluation Design and structure–activity relationships of novel inhibitors of human rhinovirus 3C protease Small peptidic aldehyde inhibitors of human rhinovirus 3C protease Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P₁ Lactam Moieties as <scp>l</scp>-Glutamine Replacements Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics New anti-viral drugs for the treatment of the common cold S-Nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease Structure-Based Virtual Screening for the Discovery of Natural Inhibitors for Human Rhinovirus Coat Protein